Navigation Links
SAFC Hitech(TM) Expands Sheboygan Facility With State-of-the-Art Manufacturing Cleanroom
Date:4/28/2008

Facility Increases In-house Capabilities and Quality Control

ST. LOUIS, April 29 /PRNewswire-FirstCall/ -- SAFC Hitech(TM), a focus area within SAFC(R), a member of the Sigma-Aldrich Group (Nasdaq: SIAL), today underlined its commitment to the electronic materials markets with the opening of a $9 million state-of-the-art cleanroom located on the Company's Sheboygan Falls, Wisconsin campus, (http://www.sigma-aldrich.com/safc-sheboygan. The 5,000 square foot facility consists of an ISO Class 4 cleanroom, a distillation suite and office space.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080429/AQTU515-a)

(Photo: http://www.newscom.com/cgi-bin/prnh/20080429/AQTU515-b)

The new facility, which became fully operational in late April 2008, provides in-house trace metals analysis and the capability to clean and fill containers in a tightly-controlled environment. The Sheboygan campus was selected as the site for the new cleanroom as it already provides large-scale manufacturing of products for the material science industry for SAFC, which supports the silicon semiconductor, compound semiconductor and performance materials markets.

The extension of the Sheboygan campus enables SAFC Hitech to produce, package and analyze its products in one location, completing the total supply chain, eliminating the need to use outside facilities and ensuring customers an uninterrupted supply of the highest quality materials required for advanced semiconductor manufacturing.

"One of S
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. SAFC Hitech(TM) Joins Aviza and ST Microelectronics for Solid State Technology ALD Webcast
2. SAFC Hitech(TM) Plans Further Expansion Into Asia
3. ATS Medical Expands Open Pivot Heart Valve Offerings
4. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
5. BioLife Solutions Expands Scientific Advisory Board
6. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
7. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment
8. Pharsight Expands Strategic Consulting Services Team
9. Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
10. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
11. AQUISS Expands Into Significant New Territory

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...stCall/ -- BioSpecifics Technologies Corp. (Nasdaq...first-in-class collagenase-based products, today a...er ended September 30, 2009. ,, "We were extre...A,s Arthritis Advisory Committee unanimously recom...(TM) for the treatment of Dupuytren,s disease, and...
(Date:11/5/2009)...FirstCall/ -- Wound Management Technologies, Inc.,...a Letter of Intent to purchase all healthcare-rela...TC Bulletin Board: VHGI). The deal provides for VH...00 shares of WNDM and a royalty agreement for reve... being acquired from VHGI. WNDM closed at $2.00 ...
(Date:11/5/2009)...rstCall/ -- WaferGen Biosystems, Inc. (OTC Bulleti...e-art genetic analysis systems, today announced th...,s Scientific Advisory Board. His career has been...lecular diagnostics for cancer detection and other...onal biology systems for several biotechnology com...
(Date:11/5/2009)...ewswire-Asia-FirstCall/ -- BMP Sunstone,Corporatio...") today announced,that the Company plans to relea... November 9, 2009, after the market closes. ,...00 pm ET on November 9, 2009,to discuss third quar...y,dialing 1-888-713-4211 or 1-617-213-4864 for int...
Breaking Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4BMP Sunstone to Report Third Quarter 2009 Financial Results 2
...rch 25 ADVENTRX Pharmaceuticals, Inc. (NYSE Amex:...fourth quarter and year ended December 31, 2008. ,...ich we advanced a new business model focused on lo...gs. We achieved important milestones with our new ...vironment, we were unable to attract financing on ...
..., March 25 Insmed Inc. (Nasdaq: INSM ), a devel...ticals, today announced that on Monday, March 23, ... suspension of the rules requiring a minimum $1 cl...m market value of publicly held shares (MVPHS). T..., July 17, 2009, and the original rules will be re...
...h 25 /PRNewswire-FirstCall/ - Oncolytics Biotech I... announced the completion of patient enrolment in ...r effects of intravenous administration of REOLYSI...n patients with advanced cancers including breast,...e Dr. Johann de Bono of The Royal Marsden NHS Foun...
Other Biology Technology:ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 2ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 3ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 4ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 5ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 6ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 7Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule 2Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial 2Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial 3
(Date:11/3/2009)..., , LAKE ALFRED, FLLaser labeling of fruit and ...a low-energy carbon dioxide laser beam is used to ...liminating the need for common sticker-type labels...riety of fruits and vegetables and is being used i...s. It has been been approved in Asia, South Africa...
(Date:11/3/2009)..., ,, WEST LAFAYETTE, Ind. - Chief executi...erpaid by about 129 times their "ideal salaries" i...lysis proposed by a Purdue University researcher t... most pressing economic and corporate governance i...ages for CEOs," said Venkat Venkatasubramanian, a ...
(Date:11/3/2009)..., , FORT COLLINS, COConsumer interest in new an...y factors including the growth of the "local foods...read reports touting its numerous health benefits,...increasing throughout the U.S. , While most groc... garlic (which is most often imported), varieties ...
Breaking Biology News(10 mins):Laser etching safe alternative for labeling grapefruit 2New theory on fairness in economics targets CEO pay 2New theory on fairness in economics targets CEO pay 3New theory on fairness in economics targets CEO pay 4Sustainably grown garlic 2Sustainably grown garlic 3superDimension Launches Second Generation iLogic 28TM 29Electromagnetic Navigation Bronchoscopy System to Detect and Diagnose Lung Cancer 5915 1superDimension Launches Second Generation iLogic 28TM 29Electromagnetic Navigation Bronchoscopy System to Detect and Diagnose Lung Cancer 5915 2superDimension Launches Second Generation iLogic 28TM 29Electromagnetic Navigation Bronchoscopy System to Detect and Diagnose Lung Cancer 5915 3Dr Julian Henley MD Presents BioMatrix Lift 5911 1Dr Julian Henley MD Presents BioMatrix Lift 5911 2Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint in a Study of Adult Subjects With a History of Grass Pollen Allergies 5907 1Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint in a Study of Adult Subjects With a History of Grass Pollen Allergies 5907 2
...t spring, the Vanderbilt greenhouse held more memb... known to exist in the wild., This unusual bounty ...ifer Ellis, a doctoral student in the biological s...of Professor David E. McCauley., The species is ca...cillatus. It was discovered in 1892 in Tennessee b...
...lfill the molecular requirements for sensing the m...und in retinal neurons of migratory birds (Mourits...tigating what parts of a migratory birds brain are...showed that the cryptochrome-containing neurons in...sen et al., PNAS, 2005; Liedvogel et al., EJN, 200...
... biologist and world-renowned expert on bird speci...ting into a recently published book, Speciation in...evolution at Chicago, evaluates the contributions ...speciation, and the roles of geographical isolatio...e discusses how nearly 10,000 bird species origina...
Other Biology News:Student study bolsters case for adding a rare sunflower to the endangered species list 2University biologist publishes book on bird speciation 2
Rabbit Anti-D-TYROSINE CONJUGATE Polyclonal Antibody, Unconjugated from AbD Serotec
Mouse Anti-Duck IgY Light Chain Monoclonal Antibody, Unconjugated, Clone 14A3 from AbD Serotec
Mouse Anti-NEUROFILAMENTS 140+160 KD Monoclonal Antibody, Unconjugated, Clone BIO-46H from AbD Serotec
Rat Anti-Rat RT1Au (Class I Polymorphic) Monoclonal Antibody, Unconjugated from AbD Serotec
Biology Products: